NightHawk Biosciences Inc (NHWK)

[dia76ca]

UPDATE: Heat Biologics to Present at the Upcoming BIO Investor Forum in San Francisco

DURHAM, NC / October 12, 2017 / Heat Biologics, Inc. ("Heat") (NASDAQ: HTBX), a biopharmaceutical company developing immunotherapies designed to activate a patient's immune system against cancer, will present during the BIO Investor Forum next week in San Francisco.
Jeff Wolf, CEO of Heat, will present at 11:15 a.m. PT, on Tuesday, Oct. 17, 2017*, with the presentation broadcast live at http://www.veracast.com/webcasts/bio/investorforum2017/83114339421.cfm for those who cannot attend. Mr. Wolf will also be available to participate in one-on-one meetings with investors registered to attend the conference.
The BIO Investor Forum is an international biotech investor conference focused on early and established private companies, as well as emerging public companies. The event features plenary sessions, business roundtables, therapeutic workshops, company presentations, and One-on-One Partnering™ meetings.